Bioxytrans Cancer Preprint Reveals Potential to Enhance Most Immunotherapy Drugs
BOSTON, MASSACHUSETTS, Jan. 10, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT)…
Clarivate Identifies Eleven Potential Blockbuster and Transformative Drugs in Annual Drugs to Watch Report
Anticipated advancements in obesity, oncology, gene therapy and other areas poised to…
Clarivate Identifies Eleven Potential Blockbuster and Transformative Drugs in Annual Drugs to Watch Report
Anticipated advancements in obesity, oncology, gene therapy and other areas poised to…
Clarivate Identifies Eleven Potential Blockbuster and Transformative Drugs in Annual Drugs to Watch Report
Anticipated advancements in obesity, oncology, gene therapy and other areas poised to…
Clarivate Identifies Eleven Potential Blockbuster and Transformative Drugs in Annual Drugs to Watch Report
Anticipated advancements in obesity, oncology, gene therapy and other areas poised to…
ULTI EX. RIGHT TO PARTICIPATE IN POTENTIAL REPAIR OFFERING TODAY
Accessibility: Skip TopNav December 18, 2024 02:00 ET | Source: Ultimovacs ASA…
Around 5 billion people 84 per cent of the potential global audience followed the Olympic Games Paris 2024
05 December 2024 - A record 84 per cent of the potential global…
TECVAYLI (teclistamab) demonstrates potential as frontline combination therapy for patients with newly diagnosed multiple myeloma
100 percent of evaluable patients for minimal residual disease (MRD) testing achieved MRD…
C4 Therapeutics Presents Cemsidomide Phase 1 Data at the American Society for Hematology (ASH) Annual Meeting that Demonstrated Potential to Become Best-in-Class IKZF1/3 Degrader
December 08, 2024 12:30 ET | Source: C4 Therapeutics, Inc. In Multiple…
Around 5 billion people 84 per cent of the potential global audience followed the Olympic Games Paris 2024
05 December 2024 - A record 84 per cent of the potential global…